This has proved problematic for more complex conditions, such as Alzheimer’s disease, where the dogged persistence in pathophysiologically defining Alzheimer’s disease by increased amyloid-β plaques and hyperphosphorylated tau-linked tangles for over 40 years has led to very little treatment improvement [13]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.